GlassScriptPhysician profile
Herbert B Newton
NPI 1770667164
$80,803.03
in general payments reported to CMS, 2019-2025
14 companies · $1,745 in 2025
The $1,745 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $21K · 2021: $7,772 · 2022: $7,331 · 2023: $6,240 · 2024: $7,187 · 2025: $1,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,613 · Food and Beverage: $2,119 · Travel and Lodging: $2,090 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,612.97 |
| Food and Beverage | $2,119.04 |
| Travel and Lodging | $2,089.68 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $25,153.14 | 2019-2025 | Optune, Optune Gio |
| Astrazeneca Pharmaceuticals LP | $14,892.00 | 2020-2021 | |
| Gt Medical Technologies, INC | $13,973.43 | 2021-2024 | Gammatile, Gammatile |
| Abbvie INC. | $12,100.00 | 2019 | |
| Monteris Medical Corporation | $8,635.12 | 2019-2023 | Neuroblate |
| Servier Pharmaceuticals LLC | $4,725.00 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,048.94 | 2019-2020 | |
| Telix Pharmaceuticals | $112.12 | 2025 | Illuccix |
| Medexus Pharma, INC. | $60.68 | 2023 | Gleolan |
| Novartis Pharmaceuticals Corporation | $37.00 | 2021 | |
| Neurelis, INC. | $35.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $16.23 | 2025 | |
| Ucb, INC. | $13.42 | 2023 | Briviact |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Newton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.